Toth Financial Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.77K | Hold |
52
| – | – | ﹤0.01% | 538 |
|
|
2025
Q1 | $5.83K | Hold |
52
| – | – | ﹤0.01% | 505 |
|
|
2024
Q4 | $4.8K | Hold |
52
| – | – | ﹤0.01% | 511 |
|
|
2024
Q3 | $4.36K | Hold |
52
| – | – | ﹤0.01% | 529 |
|
|
2024
Q2 | $3.57K | Hold |
52
| – | – | ﹤0.01% | 548 |
|
|
2024
Q1 | $3.81K | Sell |
52
-100
| -66% | -$7.33K | ﹤0.01% | 546 |
|
|
2023
Q4 | $12.3K | Buy |
152
+100
| +192% | +$8.1K | ﹤0.01% | 432 |
|
|
2023
Q3 | $3.9K | Sell |
52
-50
| -49% | -$3.75K | ﹤0.01% | 560 |
|
|
2023
Q2 | $7.86K | Sell |
102
-1
| -1% | -$77 | ﹤0.01% | 499 |
|
|
2023
Q1 | $8.55K | Buy |
103
+51
| +98% | +$4.23K | ﹤0.01% | 476 |
|
|
2022
Q4 | $4.46K | Buy |
52
+17
| +49% | +$1.46K | ﹤0.01% | 510 |
|
|
2022
Q3 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 629 |
|
|
2021
Q4 | – | Sell |
-120
| Closed | -$8K | – | 780 |
|
|
2021
Q3 | $8K | Hold |
120
| – | – | ﹤0.01% | 509 |
|
|
2021
Q2 | $8K | Hold |
120
| – | – | ﹤0.01% | 471 |
|
|
2021
Q1 | $8K | Hold |
120
| – | – | ﹤0.01% | 474 |
|
|
2020
Q4 | $7K | Sell |
120
-200
| -63% | -$11.7K | ﹤0.01% | 432 |
|
|
2020
Q3 | $20K | Sell |
320
-195
| -38% | -$12.2K | ﹤0.01% | 313 |
|
|
2020
Q2 | $40K | Buy |
515
+395
| +329% | +$30.7K | 0.01% | 237 |
|
|
2020
Q1 | $9K | Buy |
+120
| New | +$9K | ﹤0.01% | 282 |
|
|
2018
Q2 | – | Sell |
-137
| Closed | -$10K | – | 430 |
|
|
2018
Q1 | $10K | Hold |
137
| – | – | ﹤0.01% | 317 |
|
|
2017
Q4 | $10K | Buy |
+137
| New | +$10K | ﹤0.01% | 318 |
|